Ngpdt Electric Europe started in year 2013 as Private Limited Company with registration number 08758906. The Ngpdt Electric Europe company has been functioning successfully for eleven years now and its status is active. The firm's office is based in London at Eastcastle House. Postal code: W1W 8DH. Since 2019/08/05 Ngpdt Electric Europe Ltd is no longer carrying the name Biogenic Health Europe.
The firm has 2 directors, namely Krisztina B., Andor M.. Of them, Krisztina B., Andor M. have been with the company the longest, being appointed on 1 July 2019. As of 26 April 2024, there were 2 ex directors - Szabolcs L., Dora T. and others listed below. There were no ex secretaries.
Office Address | Eastcastle House |
Office Address2 | 27/28 Eastcastle Street |
Town | London |
Post code | W1W 8DH |
Country of origin | United Kingdom |
Registration Number | 08758906 |
Date of Incorporation | Fri, 1st Nov 2013 |
Industry | Wholesale of pharmaceutical goods |
Industry | Research and experimental development on biotechnology |
End of financial Year | 31st December |
Company age | 11 years old |
Account next due date | Mon, 30th Sep 2024 (157 days left) |
Account last made up date | Sat, 31st Dec 2022 |
Next confirmation statement due date | Wed, 22nd May 2024 (2024-05-22) |
Last confirmation statement dated | Mon, 8th May 2023 |
The list of PSCs who own or control the company consists of 3 names. As we established, there is Andor M. The abovementioned PSC has 50,01-75% voting rights and has 50,01-75% shares. The second one in the persons with significant control register is Krisztina B. This PSC owns 25-50% shares and has 25-50% voting rights. Then there is Szabolcs L., who also fulfils the Companies House conditions to be categorised as a person with significant control. This PSC owns 50,01-75% shares and has 50,01-75% voting rights.
Andor M.
Notified on | 1 July 2019 |
Nature of control: |
50,01-75% shares 50,01-75% voting rights |
Krisztina B.
Notified on | 1 July 2019 |
Nature of control: |
25-50% voting rights 25-50% shares |
Szabolcs L.
Notified on | 6 April 2016 |
Ceased on | 1 July 2019 |
Nature of control: |
50,01-75% shares 50,01-75% voting rights right to appoint and remove directors |
Biogenic Health Europe | August 5, 2019 |
Profit & Loss | |||||||||
---|---|---|---|---|---|---|---|---|---|
Accounts Information Date | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
Net Worth | -52 326 | -165 280 | -305 544 | ||||||
Balance Sheet | |||||||||
Cash Bank On Hand | 1 324 | 1 063 | 1 149 | 1 274 | 741 | ||||
Current Assets | 1 261 408 | 1 146 296 | 1 008 742 | 857 489 | 733 351 | 612 370 | 491 447 | 370 372 | 248 740 |
Debtors | 1 239 528 | 1 101 942 | 974 113 | 731 656 | 611 045 | 490 036 | 368 836 | 247 737 | |
Net Assets Liabilities | 305 544 | 454 051 | 575 924 | -656 653 | -779 990 | -902 790 | -1 025 005 | ||
Cash Bank In Hand | 21 880 | 16 828 | 7 103 | ||||||
Intangible Fixed Assets | 1 089 937 | ||||||||
Net Assets Liabilities Including Pension Asset Liability | -52 326 | -150 220 | -305 544 | ||||||
Stocks Inventory | 27 526 | 27 526 | |||||||
Reserves/Capital | |||||||||
Called Up Share Capital | 100 | 100 | 100 | ||||||
Profit Loss Account Reserve | -52 426 | -165 380 | -305 644 | ||||||
Shareholder Funds | -52 326 | -165 280 | -305 544 | ||||||
Other | |||||||||
Average Number Employees During Period | 2 | 2 | 2 | 2 | |||||
Creditors | 10 302 | 7 556 | 3 096 | 1 280 483 | 1 282 897 | 1 284 622 | 1 285 205 | ||
Current Asset Investments | 262 | 262 | 262 | 262 | |||||
Fixed Assets | 4 813 | 4 813 | 11 460 | 11 460 | 11 460 | 11 460 | 11 460 | 11 460 | 11 460 |
Investments | 11 460 | 11 460 | 11 460 | 11 460 | 11 460 | ||||
Investments Fixed Assets | 4 813 | 4 813 | 11 460 | 11 460 | 11 460 | 11 460 | 11 460 | 11 460 | |
Net Current Assets Liabilities | 1 231 236 | 1 136 819 | 998 440 | 849 933 | 730 255 | 612 370 | 491 447 | -914 250 | -1 036 465 |
Total Assets Less Current Liabilities | 1 236 049 | 1 141 632 | 1 009 900 | 861 393 | 741 715 | 623 830 | 502 907 | -902 790 | -1 025 005 |
Advances Credits Directors | 418 | 1 270 473 | 1 271 547 | 1 273 862 | 1 275 794 | 1 276 294 | |||
Advances Credits Made In Period Directors | 1 270 055 | 1 074 | 2 314 | 1 931 | |||||
Creditors Due After One Year | 1 288 375 | 1 306 912 | 1 315 444 | ||||||
Creditors Due Within One Year | 30 172 | 9 477 | 10 302 | ||||||
Intangible Fixed Assets Additions | 1 211 041 | ||||||||
Intangible Fixed Assets Aggregate Amortisation Impairment | 121 104 | ||||||||
Intangible Fixed Assets Amortisation Charged In Period | 121 104 | ||||||||
Intangible Fixed Assets Cost Or Valuation | 1 211 041 |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with no updates 2023/05/08 filed on: 19th, May 2023 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy